EPGL Stock Updates 08/26/2014 10:25:28 $EPGL So this

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
EPGL Stock Updates 08/26/2014 10:25:28 $EPGL
So this morning seemed to be a taste of the sell on the news mentality….maybe it's better to have it happen now rather than over the long weekend. I hope an announcement also comes from the NYSE partner…I hope….I really hope.
I love how you guys can break it down to a science....kind of like football play by play. Not sure based on the tweet....that we are gonna get more than who the agreement is with.....maybe some indication of the terms. I'm hopefull for more. EPGL long!!

EPGL Stock Message Board http://investorshangout.com/EP-Global-Communi...PGL-87206/

It' all good, needed to have a "cleansing" if you will,,,before we move upwards and break into new highs, will make for stronger move



$$$$$$ EPGL $$$$$$$
Nite is holding down to get more shares.
Will move up soon.
EPGL Organic play->Zero Dilution, Zero Toxic Debt, Real Technology!

PricewaterhouseCoopers (World's largest accounting firm) & EPGL Insiders control the majority of the O/S

Float Tightly held



MD+DI Article Nice article on EPGL from a leading industry source.

Will EPGL's TopSpin Serve Up the Next Generation of Medical Devices?

A former DARPA scientist and a device startup want to change medical devices forever using bioMEMS

A phone call with EPGL Medical Science is not unlike a game of Texas hold 'em, you don't know exactly what the guys across the table are holding, but you definitely know you should at least be paying attention. MD+DI profiled EPGL last month when the company announced it would be among the first medical device companies to implement Google Glass technology. But company president and CEO Michael Hayes was more excited about something else going on at EPGL – a bioMEMS platform, codenamed TopSpin, that EPGL says will usher in nothing short of a paradigm shift for medical devices and the doctors and patients that use them. The goal is to do for medical devices what Steve Jobs did for phones.

The ace in the hole is Dr. David T. Markus, the company's VP of bioMEMS development. Markus comes to the company with an extensive background in MEMS, microelectronics, and biomedical engineering. He was also a principal investigator at DARPA, where the forefront of MEMS research has been conducted for years. “They brought together the best scientists in America, essentially doing research that is so advanced, it has little practical use, but not in all cases” Markus laughs. “As a result of being part of those programs and others, some new advanced technology was developed and I just so happened to be involved in the development of some of those technologies. As a result I was able to know how to replicate them for practical use in the medical field.”




Dr. David Markus wants to serve up the world's most advanced medical devices

Markus, who is fluent in seven languages, speaks with an ease that belies just how large of an impact he's attempting to have on the medical device industry. And if Hayes' boast that EPGL is “Three to five years ahead of any device company in this field because of David Markus,” is true, perhaps he should. He and Hayes met as friends on the tennis court and later bonded when Hayes began speaking with him about ideas for new and improved medical devices. “I had all of these ideas and hadn't realized I was contemplating MEMS ideas,” Hayes says. “David has given me quite an education on what the possibilities are with MEMS. Based on that I've made a decision that EPGL is going to be a company focused largely on advanced MEMS devices.”



MEMS technology has already impacted a variety of fields from robotics, to personal fitness, and even digital movie projection. Markus and the team at EPGL figure it is medtech's turn. “The reason why we're very confident is because this isn't dreamland stuff, this is technology that exists right now,” Hayes says. “Everything David is working on is technology that he knows how to implement.”



So what is TopSpin exactly? Or, more accurately, what does it hope to become? Imagine all of the devices doctors now use in the hospital and clinical setting for a wide variety of procedures. Some of these devices and machines are large and require designated rooms in the clinic or hospital for use. Now imagine many of those devices sharing the same core platform with advanced MEMS technology, making them much smaller, less invasive and more effective and you have the beginnings of what TopSpin promises. While Markus and his team are sworn to secrecy for full details, he does promise “Topspin will be small and noninvasive. It will be packed with all necessary smart systems. It can achieve 1 micron in movement. And it is an intelligent microsystem with advanced technology that no Fortune 500 company owns.”




A sample of bioMEMS technology for drug delivery previously developled by Dr.Markus

Markus wants clinicians to feel the same impact with TopSpin that consumers did with the touchscreen not too long ago. “It was shocking when the iPhone finally came to market. People said, 'Wow I didn't know a touchscreen could be this dynamic' “ Markus says. “ I'm sure you remember before the iPhone that the touchscreen experience was only as good as a PDA with stylus. But look at something like Gorilla Glass. It was developed by Corning in 1960 but was put on a shelf. Nobody knew it existed until Apple started using it in the iPhone.” While he remains close-lipped about much of his DARPA background Markus, very modestly, states that “You'd be amazed how much technology is out there and is available in the world.”



Hayes likes to extend the iPhone analogy when talking about TopSpin. Just as the iPhone is more than a phone and functions as a platform for application development (ala the AliveCor heart monitor), so too will TopSpin be a platform for medical device applications. The key distinction is that EPGL doesn't want to create Star Trek-style TriCorder. “We're not saying you'll hold one single device in your hand and it'll do everything,” Hayes says. “ We've developed a platform by which many different MEMS devices can be spawned, but it's all based on two or three components to the main device. But literally dozens and dozens of new devices can result from this one single device. It'll result in several unique patented devices.” As of late Markus and his team are already boasting 10, as yet to be revealed, pain management devices that have been created with the platform. Hayes predicts that anywhere up to five of these devices should be in the prototype phase and undergoing FDA 510(k) applications by fourth quarter 2013.



“The gist of it is is that we're taking bioMEMS technology, utilizing nature and the senses we have as living creatures such as touch, taste, sight, sound, balance, and giving these senses to devices. It's the ability for devices to almost become superhuman,” Hayes says.



“Take a doctor who would never consider doing a certain procedure now because they don't have the facilities or they would normally have to perform the procedure in a hospital or O.R. setting. What we're offering is several devices that will give physicians who don't have the current ability to do certain procedures the ability to do these procedures in a clinical setting in a compact and effective way,” Hayes continues.



If EPGL's ambitions ring true one won't be able to deny the inherent cool factor of the TopSpin. But Markus is quick to emphasize that this is not invention or innovation for the sake of doing so. There's a real goal in helping doctors in speeding up patient recovery and, ultimately, in reducing medical costs. “The device will be produced based on doctors' feedback when treating patients,” he says. “It's not based on any engineer notions of what's good for the doctor. We asked doctors what they needed.”



A paradigm shift? Game changer? Both Hayes and Markus acknowledge how lofty their words must sound, especially without a finished device yet revealed to the public. But Hayes carries himself like a player who knows he has a winning hand, he just needs to wait his turn. “I realize the Fortune 500 companies like Medtronic or St. Jude will look at us and scoff like we're another newcomer trying to thump their chest,” Hayes says. “And to some extent they're right because we're a pittance compared to them currently financially. But we have technology that we know they would love to have and that's what makes us something meaningful and something to recon with in the future.”



Confidence certainly, but as any experienced player will tell you only time will tell whether EPGL is holding the winning cards or have merely mastered the art of the bluff. Still, one gets the sense that Hayes has no trouble looking you in the eye when he says, “We're trying to usher in the era of the smart medical device- smarter medical devices... the smartest medical devices.”



-Chris Wiltz, Associate Editor, MD+DI

$EPGL
#MEMS



Looking at the T&S tape, the MM's took 44 seconds, and 66,600 shares to drop it from 0.06 to 0.0515!!

Percentage wise, it a big drop in 44 seconds, but the volume of 66,600 shares lets you know that the MM's were simply trying to accumulate shares, balance their books (which didn't work), and hit stop losses.

Go EPGL
Also the tweet just said EPGL will be making an announcement after-hours in friday. It did not say that the NYSE partner will not make one to go with it. I expect both parties to make a joint announcement on Friday.
Almost jumped on 52s but wasn't sure how much more they were going to walk it down. Took my first position at 62 and still can't believe I got in at that level... Looking awesome here! GLTA
What a great buying opportunity! I'm kinda shocked in away it went below my "Peek a boo"support line I had drawn not too long ago... Boy.., talking about Peek a boo for real, it won't surprise me bit if we close at near where we started it or just slightly above it! Shake that tree baby.. Shake that tree!!! Hahhaha
Like I have said off and on KNOW WHAT YOU OWN, do not let others fool you or trick you out of your shares!

$$$$$ EPGL $$$$$$
That was a big league...shakeout. Ridiculous how they scare people into selling. Now I have to apologize to whomever said we were going to 5 cents!! Ugg people I was down over 6 figures today.....still smiling because EPGL is so undervalued. I hope some longs picked up more. Anyone who sold will be kicking themselves in a few weeks.....or next week.
I wonder how the person that got tricked/scarred out of his shares at .0517 feels now.
Yup .05s now .07s hitting
Might be green by 11am my time.
Herd mentality buying should begin today...can't wait for 3:00pm today!

Go EPGL
Well yeah,,, lol
07 printed , ask is thin upwards
Going to break previous highs.
EPGL

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 53

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 119

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
AI Shopping Answers Are Becoming Retail's New Shelf

Updated Category News Views 67

Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...

Continue Reading
Tigo's Guidance Gap Draws Lawsuit and Investor Scrutiny

Updated Category News Views 84

A Revenue Promise Hit the Wall Solar investing can turn ugly in a hurry when a supposedly near-term catalyst gets shoved down the calendar. That is the central bruise behind the securities class action involving Tigo Energy, not some arcane accounting footnote that only lawyers can love. The complaint alleges Tigo overstated the revenue contribution it expected from its...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 70

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading

Top 5 Most Recently Viewed Articles

NANO Nuclear Energy Partners with Cambridge Atom Works for ODIN Sale

Updated Category News Views 195

NANO Nuclear Energy Partners with Cambridge Atom Works for ODIN Sale NANO Nuclear Energy Inc. has made a pivotal move by signing a letter of intent to sell its innovative ODIN™ low-pressure coolant reactor technology. This strategic decision not only signifies NANO Nuclear's commitment to optimizing their technology portfolio but also enables a sharper focus on their...

Continue Reading
Project C.U.R.E. and Microsoft: Transforming Global Health Access

Updated Category News Views 244

Transforming Global Healthcare Through Innovative Partnerships In a world where access to essential healthcare is still a significant challenge, Project C.U.R.E. has teamed up with Microsoft to make a meaningful difference. This collaboration aims to change the lives of millions by providing vital medical resources to underserved populations. With over 4.5 billion people...

Continue Reading
How STRADVISION Is Leading the Charge in Automotive Innovation

Updated Category News Views 395

Transforming the Automotive Industry: STRADVISION's Role STRADVISION, a pioneer in deep learning-based vision perception technology, is at the forefront of a revolution in the automotive industry. Their latest edition of the STRADVISION Market Intelligence Report delves into significant trends transforming the automotive landscape, influenced by advancements in autonomous...

Continue Reading
Holdings and Legal Developments: Atkore Inc. Class Action Insight

Updated Category News Views 182

Understanding the Atkore Inc. Class Action Lawsuit In recent developments, Atkore Inc. (NASDAQ: ATKR) is facing a class action lawsuit that has raised significant attention among investors. The lawsuit, officially titled Westchester Putnam Counties Heavy & Highway Laborers Local 60 Benefits Fund v. Atkore Inc., highlights serious allegations against the company and its...

Continue Reading
Brenda Snow's Empowering New Book for Patients on Health Journey

Updated Category News Views 279

Brenda Snow's Inspiring Book on Navigating Health Challenges Brenda Snow's upcoming book is generating buzz as a vital resource for individuals grappling with serious health issues. This essential guide, titled Diagnosed: The Essential Guide to Navigating the Patient's Journey, is set to empower patients and caregivers alike. A Personal Narrative That Inspires In her...

Continue Reading